TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026

Efficacy and Safety of Biosimilar AVT05 Versus Reference Product Golimumab in Combination with Methotrexate in Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results of a Randomized, Parallel-Group, Double-Blind Study.

Monica Luque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.